Neurochemistry of brain lesions determined by spectroscopic imaging in systemic lupus erythematosus

Journal of Rheumatology

Volumn 24, Issue 12, 1997, Pages 2323-2329

  Brooks, William M ^a   Sabet, Arman ^a   Sibbitt Jr , Wilmer L ^a   Barker, Peter B ^b   Van Zijl, Peter C M ^c   Duyn, Jeff H ^d   Moonen, Chrit T W ^d  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b HENRY FORD HOSPITAL   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Brain injuries; Neurochemistry; Nuclear magnetic resonance; Spectroscopy; Systemic lupus erythematosus

Indexed keywords

CHOLINE; CREATINE; LACTIC ACID; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; BRAIN DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMYELINATION; FEMALE; GRAY MATTER; HUMAN; MALE; NERVE CELL LESION; NEUROCHEMISTRY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; WHITE MATTER;

ADULT; ASPARTIC ACID; BIOLOGICAL MARKERS; CEREBRAL VENTRICLES; CHOLINE; CREATINE; FEMALE; HUMANS; LACTIC ACID; LUPUS ERYTHEMATOSUS, SYSTEMIC; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NERVE FIBERS; NEURONS; OCCIPITAL LOBE;

EID: 0031465563     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Bluestein HG: Nervous system in systemic lupus erythematosus. Immunol Allergy Clin North Am 1988;8:315-3.
2. Ginzler EM, Schorn K: Outcome and prognosis in systemic lupus erythematosus. Rheum Dis Clin North Am 1988;14:67-78.
3. Johnson RT, Richardson EP: The neurological manifestations of systemic lupus erythematosus. A clinical-pathological study of 24 cases and review of the literature. Medicine 1968;47:337-69.
4. Ellis SG, Verity MA: Central nervous systemic involvement in systemic lupus erythematosus: A review of neuropathological findings in 57 cases, 1955-1957. Semin Arthritis Rheum 1979;8:212-21.
5. West SG: Neuropsychiatric lupus. Rheum Dis Clin North Am 1994;20:129-58.
6. Aisen AM, Gabrielsen TO, McCune WJ: MR imaging of systemic lupus erythematosus involving the brain. Am J Radiol 1985;144:1027-31.
7. Fields RA, Sibbitt WL, Toubbeh H, Bankhurst AD: Neuropsychiatric lupus erythematosus, cerebral infarctions, and anticardiolipin antibodies. Ann Rheum Dis 1990;49:114-7.
8. Ishikawa O, Kazunori O, Miyachi Y, Ishizaka H: Cerebral lesions in systemic lupus erythematosus detected by magnetic resonance imaging. Relationship to anticardiolipin antibody. J Rheumatol 1994;21:87-90.
9. Sibbitt WL Jr, Sibbitt RR, Griffey RH, Eckel CG, Bankhurst AD: Magnetic resonance and CT imaging in the evaluation of acute neuropsychiatrie disease in systemic lupus erythematosus. Ann Rheum Dis 1989;4:1014-22.
10. Jarek M, West SG, Baker MR, Rak KM: Magnetic resonance imaging in systemic lupus erythematosus patients without a history of neuropsychiatric lupus erythematosus. Arthritis Rheum 1994;37:1609-13.
11. Sibbitt WL Jr, Sibbitt RR: Magnetic resonance spectroscopy and positron emission tomography scanning in neuropsychiatrie systemic lupus erythematosus. Rheum Dis Clin North Am 1993;19:851-68.
12. Sibbitt WL Jr, Haseler LH, Griffey RH, Hart BL, Sibbitt RR, Matwiyoff NA: Analysis of cerebral structural changes in systemic lupus erythematosus by proton magnetic resonance spectroscopy. AJNR (Am J Neuroradiol) 1994;45:923-8.
13. Sibbitt WL Jr, Brooks WM, Haseler LJ, et al: Spin-spin relaxation of brain tissues in systemic lupus erythematosus. Arthritis Rheum 1995;38:810-18.
14. Tan EM, Cohen AS, Fries JF, et al: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
15. Carbotte RM, Denburg JA: Prevalence of cognitive impairment in systemic lupus erythematosus. J Nerve Mental Dis 1986;174:357-64.
16. Duyn JH, Griffen J, Sobering G, van Zijl PCM, Moonen CTW: Multisection proton spectroscopy imaging of the brain. Radiology 1993;188:277-82.
17. Moonen CTW, Sobering G, van Zijl PCM, Gillen J, von Kienlin M, Bizzi A: Proton spectroscopic imaging of human brain. J Mag Reson 1992;98:556-75.
18. Moonen CTW, van Zijl PCM: Highly efficient water suppression for in vivo proton NMR spectroscopy. J Magn Reson 1990;88:28-41.
19. Bluestein HG: Neuropsychiatric disorders in systemic lupus erythematosus. In: Lahita RG, ed. Systemic Lupus Erythematosus. New York: John Wiley, 1987:593-614.
20. Johnson PC, Spetzler RF, Hodak JA: Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. II. Postmortem pathologic correlations. Stroke 1986;17:1090-7.
21. Zimmerman RD, Fleming CA, Lee BC, Saint-Louis LA, Deck MD: Periventricular hyperintensities as seen by magnetic resonance: Prevalence and significance. AJNR (Am J Neuroradiol) 1986;146:443-50.
22. Helpern JA, Dereski MO, Knight RA, Ordidge RJ, Chopp M, Qing ZX: Histopathological correlations of nuclear magnetic resonance imaging parameters in experimental cerebral ischemia. Magn Reson Imag 1993;11:241-6.
23. Denburg SD, Denburg JA, Carbotte RM, Fisk JD, Hanly JG: Cognitive deficits in systemic lupus erythematosus. Rheum Dis Clin North Am 1993;19:815-31.
24. Denburg S, Carbotte RM, Denburg JA: Corticosteroids and neuropsychological functioning in patients with systemic lupus erythematosus. Arthritis Rheum 1994;37:1311-20.
25. Hunt AL, Orrison WW, Yeo RA, et al: Clinical significance of MRI white matter lesions in the elderly. Neurology 1989;39:1470-4.
26. Koller KJ, Zaczek R, Coyle JT: N-acetyl-aspartyl-glutamate: Region levels in rat brain and the effects of brain lesions as determined by a new HPLC method. J Neurochem 1984;43:1136-42.
27. Frahm J, Bruhn H, Gyngell ML, Merboldt KD, Haenicke W, Sauter R: Localized high resolution proton NMR spectroscopy using stimulated echoes: Initial application to human brain in vivo. Magn Reson Med 1989;9:19-93.
28. Barker PB, Breiter SN, Sober BJ, et al: Quantitative proton spectroscopy of canine brain: In vivo and in vitro correlations. Magn Reson Med 1994;32:157-63.
29. Griffey RH, Brown MS, Bankhurst AD, Sibbitt RR, Sibbitt WL Jr: Depletion of high-energy phosphates in the central nervous system of patients with systemic lupus erythematosus, as determined by phosphorus-31 nuclear magnetic resonance spectroscopy. Arthritis Rheum 1990;33:827-33.
30. Urenjak J, Williams SR, Gadian DG, Noble M: Specific expression of N-acetylaspartate in neurons, oligodendrocyte-Type-2 astrocyte progenitors and immature oligodendrocytes in vitro. J Neurochem 1992;59:55-61.
31. Barker PB, Gillard JH, van Zijl PCM, et al: Acute stroke: Evaluation with serial proton magnetic resonance spectroscopic imaging. Radiology 1994;192:723-32.
32. Davie CA, Hawkins CP, Barker GJ, et al: Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 1994;117:49-58.
33. Shiino A, Matsuda M, Morikawa S, et al: Proton magnetic resonance spectroscopy with dementia. Surg Neurol 1993;39:143-7.
34. 1H-MRS of stroke. Neurol 1992;42:1408-12.
35. Sharma R, Venkatasubramanian PN, Barany M, Davis JM: Proton magnetic resonance spectroscopy of the brain in schizophrenic and affective patients. Schizo Res 1992;8:43-9.
36. Petroff OAC, Graham GD, Blamire AM, et al: Spectroscopic imaging of stroke in humans: Histopathology correlates of spectral changes. Neurology 1992;42:1349-59.
37. de Stefano N, Matthews PM, Arnold DL: Reversible decreases in N-acetylaspartate after acute brain injury. Magn Reson Med 1995;34:721-7.
38. Brenner RE, Munro PMG, Williams SCR, et al: The proton NMR spectrum in acute EAE: The significance of the change in the Cho:Cr ratio. Magn Reson Med 1993;29:737-45.
39. Oppenheimer SM, Bryan RN, Conturo TE, Soher BJ, Preziosi TJ, Barker PB: Proton magnetic resonance spectroscopy and gadolinium-DTPA perfusion imaging of asymptomatic MRI white matter lesions. Magn Reson Med 1995;33:61-8.
40. Bruhn H, Frahm J, Gyngell ML, Merboldt KD, Hanicke W, Sauter R: Cerebral metabolism in man after acute stroke: New observations using localized proton NMR spectroscopy. Magn Res Med 1989;9:126-31.
41. Blamire AM, Graham GD, Rothman DL, Prichard JW: Proton spectroscopy of human stroke: Assessment of transverse relaxation times and partial volume effects in single volume steam MRS. Magn Reson Imag 1994;12:1227-35.
42. Davie SE, Newcombe J, Williams SR, McDonald WI, Clark JB: High resolution proton NMR spectroscopy of multiple sclerosis lesions. J Neurochem 1995;64:742-8.
43. Mathews VP, Barker PB, Blackband SJ, Chatham JC, Bryan RN: Cerebral metabolites in patients with acute and subacute strokes: Concentrations determined by quantitative proton MR spectroscopy. Am J Radiol 1995;165:633-8.
44. Meyer GJ, Schober O, Stoppe G, Wildhagen K, Seidel JW, Hundeshagen H: Cerebral involvement in systemic lupus erythematosus (SLE): Comparison of positron emission tomography (PET) with other imaging methods. Psychiatry Res 1989;29:367-8.
45. 1H nuclear magnetic resonance spectroscopy. II. Changes during ischemia. J Cereb Blood Flow Metab 1987;7:394-402.
46. Soher BJ, van Zijl PCM, Duyn JH, Barker PB: Quantitative proton spectroscopic imaging of the human brain. Magn Reson Med